BofA lowered the firm’s price target on Ibotta (IBTA) to $90 from $110 and keeps a Buy rating on the shares. Q3 results came in above consensus on revenue and EBITDA, but Ibotta guided to Q4 sales and EBITDA that missed consensus and management attributed the weaker Q4 guidance on exhaustion of CPG budgets, as there is a mismatch between demand and supply, the analyst tells investors. The firm lowered its estimates on near-term uncertainty following the report.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBTA: